作为帕金森病的潜在疗法,远程缺血调节:抑制TLR4驱动的神经炎症和氧化损伤
Lipeng Cai1, Yuchuan Ding2, Abdullah Al Tekreeti2
1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China; Department of Neurology, Beijing Luhe Hospital, Capital Medical University, Beijing, China; China-America Institute of Neuroscience, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
Brain research
|September 3, 2025
概括
远程缺血调节 (RIC) 和运动 (EXE) 通过减少神经炎症和氧化应激,为帕金森病 (PD) 提供可比的神经保护. 这是一个有希望的,可访问的PD康复替代方案.
科学领域:
- 神经科学
- 神经退行性疾病
- 康复医学
背景情况:
- 帕金森病 (PD) 影响全球数以百万计的人,
- 运动 (EXE) 可以改善PD运动症状,但由于症状的严重程度,患者的坚持是有限的.
- 远程缺血调节 (RIC) 是一种具有神经保护潜力的非侵入性,低成本的干预措施,为EXE提供了替代方案.
研究的目的:
- 在帕金森病小鼠模型中评估RIC与EXE的疗效.
- 研究RIC和EXE在PD中的神经保护机制.
主要方法:
- 在使用MPTP注射的小鼠中诱导了帕金森病.
- 在14天的时间里,小鼠被分为控制,PD,EXE (跑步机训练) 和RIC (四肢缺血-再输血) 组.
- 评估了运动性能,多巴胺基性神经退行,神经炎症和氧化应激标志物.
主要成果:
- RIC和EXE都显著改善了运动功能,并减少了多巴胺神经退行.
- 干预措施降低了α-synuclein的积累,并恢复了氨酸基酶 (TH) 的表达.
- RIC和EXE抑制了微质激活,减少了神经炎症 (TLR4/ NF- kB通路),并减轻了氧化应激.
结论:
- 主要通过减轻TLR4介导的神经炎症和氧化损伤,RIC和EXE在PD中表现出相似的神经保护作用.
- 对于PD患者来说,RIC是一种有前途的,易于使用的康复策略.
- RIC的非侵入性和易于使用使其成为一个可行的治疗选择.
相关概念视频
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702


